Aortic & peripheral vascular disease

Outcomes of atherectomy in patients undergoing lower extremity revascularisation

EuroInterventionPublished Retrospective cohort study

Main finding · Major amputationResult — go to the resultAdjusted hazard ratio 0.67 95% CI 0.51–0.85

Authors' conclusion

The use of atherectomy during PVI is common and is not associated with an increase in IH adverse events. Longitudinally, patients treated with atherectomy undergo repeat endovascular reintervention more frequently but experience a reduced risk of amputation and surgical revascularisation.

Study context

Population
Patients undergoing lower extremity peripheral vascular intervention (PVI), NCDR PVI Registry, 2014–20196,889 with out-of-hospital data
Participants
30,847 patients
Exposure
PVI with atherectomy vs without atherectomy
  • Atherectomyn = 10,971
Outcome
Major amputation
Follow-up
1 year
Methodological detailsregistry-based
  • Registry-based

Main finding

As reported in the abstract

Adjusted hazard ratio

0.67

95% CI 0.51–0.85

P < 0.01

Atherectomyvs Non-atherectomy
aHR 0.67 (95% CI 0.51–0.85); P < 0.01

Observational data: associations, not effects.

Secondary outcomes

OutcomeaHR (95% CI)P value
Surgical revascularisation · 1 year0.63 (0.44–0.89)P = 0.017
Endovascular revascularisation · 1 year1.21 (1.06–1.39)P < 0.01

Death · 1 year

No difference in death rates
P = 0.10

Safety

IH composite (procedural complications, bleeding or thrombosis) · in-hospital · rates per procedure, unadjusted

In-hospital (IH) composite (procedural complications, bleeding or thrombosis) — Unadjusted difference
p=0.07
IH composite (procedural complications, bleeding or thrombosis) — After adjustment, atherectomy not associated with increased risk
p=0.68

Original publication

Outcomes of atherectomy in patients undergoing lower extremity revascularisation. EuroIntervention. Published 18 December 2023. doi:10.4244/eij-d-23-00432

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.